Triple-negative breast cancer (TNBC) is one of the most aggressive and difficult-to-treat forms of breast cancer. Unlike other types, TNBC lacks the three main receptors—estrogen, progesterone, and HER2—which are commonly targeted in treatment. This makes finding effective therapies a significant challenge. However, recent research suggests that a plant-derived compound could help fight this deadly […]